Vanguard Investments Australia’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.7M Buy
41,665
+684
+2% +$180K 0.03% 447
2026
Q1
$10.9M Buy
+40,981
New +$11.1M 0.03% 434

Other funds holding LH

Vanguard Investments Australia's LH Position: Q2 2026 in Review

Vanguard Investments Australia increased its Labcorp (LH) stake by 1.7% in Q2 2026, buying an estimated $180K and bringing the position to 41,665 shares worth $11.7M. The position accounts for 0.03% of the portfolio, ranked #447.

Vanguard Investments Australia first reported a position in LH in Q1 2026 and has held it in 2 quarters since. 1,051 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Vanguard Investments Australia held 41,665 shares of Labcorp worth $11.7M as of Q2 2026.
  • Vanguard Investments Australia bought 684 Labcorp shares in Q2 2026, an estimated $180K.
  • Labcorp made up 0.03% of Vanguard Investments Australia's portfolio in Q2 2026, its #447 holding.
  • Vanguard Investments Australia first reported a position in Labcorp in Q1 2026 and has held it in 2 quarters since.
  • 1,051 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Vanguard Investments Australia's 13F filing for Q2 2026, filed 13 Aug 2026.